Humacyte Ratios (2024-2025) | HUMA

Ratios Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Profitability
Gross Margin (Quarter) 71.57%29.24%65.47%-1,844.75%
EBT Margin (Quarter) -4,936.56%-10,445.18%-3,507.57%-7,149.68%
EBIT Margin (Quarter) -4,484.33%-9,876.08%-3,239.04%-6,595.07%
EBITDA Margin (Quarter) 7,570.41%-12,510.96%-2,325.37%-6,595.07%
Operating Margin (Quarter) -4,484.33%-9,876.08%-3,239.04%-6,595.07%
Net Margin (Quarter) -4,936.56%-10,445.18%-3,507.57%-7,149.68%
FCF Margin (Quarter) -5,637.33%-8,854.15%-3,180.48%-5,597.22%
Efficiency
Inventory Average (Quarter) 9.56M14.75M20.45M
Assets Average (Quarter) 149.87M126.52M126.32M150.21M150.67M115.15M103.94M
Equity Average (Quarter) -1.07M-46.00M-58.20M-8.31M20.05M-0.35M-0.82M
Invested Capital (Quarter) 84.11M31.79M-1.60M-52.67M102.41M72.59M25.07M38.55M
Asset Utilization Ratio (Quarter) 0.000.010.010.02
Leverage & Solvency
Interest Coverage Ratio (Quarter) -14.65-11.73-12.40-11.20-7.73-11.68-9.34-9.96
Debt to Equity (Quarter) 2.22-2.12-0.97-1.241.8416.92-4.37
Debt Ratio (Quarter) 0.360.430.540.470.410.490.23
Equity Ratio (Quarter) 0.16-0.20-0.56-0.380.220.03-0.050.03
Times Interest Earned (Quarter) -14.65-11.73-12.40-11.20-7.73-11.68-9.34-9.96
Valuation
Enterprise Value (Quarter) -115.50M-93.60M-20.57M-44.94M-62.80M-38.03M-19.49M-50.50M
Return Ratios
Return on Sales (Quarter) -49.37%-104.45%-35.08%-71.50%
Return on Capital Employed (Quarter) -1.08%-0.85%-0.86%-1.18%-1.26%
Return on Assets (Quarter) -0.95%-0.78%-0.79%-0.98%-1.12%
Return on Equity (Quarter) 2.06%14.16%-5.91%323.66%142.22%